Observe Medical ASA (OSL: OBSRV)
Norway
· Delayed Price · Currency is NOK 0.330
-0.069 (-17.29%)
Dec 23, 2024, 9:00 AM CET
Observe Medical ASA Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Revenue | 29.18 | 27.94 | 19.52 | 24.04 | 2.96 | 0.18 | Upgrade
|
| Revenue Growth (YoY) | 50.94% | 43.14% | -18.80% | 711.96% | 1572.88% | 66.69% | Upgrade
|
| Cost of Revenue | 19.18 | 18.66 | 14.34 | 14.52 | 1.98 | 0.64 | Upgrade
|
| Gross Profit | 10 | 9.29 | 5.18 | 9.52 | 0.99 | -0.46 | Upgrade
|
| Selling, General & Admin | 18.25 | 24.22 | 27.31 | 17.26 | 10 | 4.28 | Upgrade
|
| Other Operating Expenses | 19.26 | 22.76 | 26.08 | 20.72 | 15.91 | 6.76 | Upgrade
|
| Operating Expenses | 51.09 | 60.55 | 64.32 | 41.44 | 29.07 | 15.33 | Upgrade
|
| Operating Income | -41.09 | -51.26 | -59.14 | -31.93 | -28.09 | -15.79 | Upgrade
|
| Interest Expense | -4.08 | -6.65 | -3.82 | -3.33 | -2.53 | -1.28 | Upgrade
|
| Interest & Investment Income | - | 0.06 | 0.28 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -4.28 | -4.28 | 1.64 | 4.64 | 3.85 | 0.37 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.02 | -0.03 | 0.65 | -0.43 | -0.13 | - | Upgrade
|
| EBT Excluding Unusual Items | -49.47 | -62.15 | -60.39 | -31.04 | -26.9 | -16.7 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | -4.62 | - | - | Upgrade
|
| Other Unusual Items | 1.81 | 1.81 | 9.67 | 9.34 | -9.97 | -0.22 | Upgrade
|
| Pretax Income | -47.67 | -60.35 | -50.73 | -26.32 | -36.87 | -16.92 | Upgrade
|
| Income Tax Expense | 0.02 | 0.02 | 0.08 | - | - | - | Upgrade
|
| Net Income | -47.68 | -60.36 | -50.8 | -26.32 | -36.87 | -16.92 | Upgrade
|
| Net Income to Common | -47.68 | -60.36 | -50.8 | -26.32 | -36.87 | -16.92 | Upgrade
|
| Shares Outstanding (Basic) | 126 | 58 | 47 | 20 | 17 | 12 | Upgrade
|
| Shares Outstanding (Diluted) | 126 | 58 | 47 | 20 | 17 | 12 | Upgrade
|
| Shares Change (YoY) | 135.74% | 22.13% | 140.67% | 18.29% | 33.64% | 4.51% | Upgrade
|
| EPS (Basic) | -0.38 | -1.05 | -1.08 | -1.34 | -2.22 | -1.36 | Upgrade
|
| EPS (Diluted) | -0.38 | -1.05 | -1.08 | -1.34 | -2.22 | -1.36 | Upgrade
|
| Free Cash Flow | -18.61 | -32.47 | -52.74 | -22.34 | -22.88 | -16.11 | Upgrade
|
| Free Cash Flow Per Share | -0.15 | -0.56 | -1.12 | -1.14 | -1.38 | -1.30 | Upgrade
|
| Gross Margin | 34.26% | 33.24% | 26.52% | 39.59% | 33.30% | -259.89% | Upgrade
|
| Operating Margin | -140.83% | -183.46% | -302.97% | -132.79% | -948.53% | -8918.64% | Upgrade
|
| Profit Margin | -163.41% | -216.03% | -260.24% | -109.48% | -1245.12% | -9557.63% | Upgrade
|
| Free Cash Flow Margin | -63.79% | -116.22% | -270.16% | -92.94% | -772.71% | -9103.39% | Upgrade
|
| EBITDA | -31.8 | -41.97 | -51.61 | -31.11 | -26.32 | -12.94 | Upgrade
|
| EBITDA Margin | -108.97% | -150.20% | -264.36% | -129.38% | - | - | Upgrade
|
| D&A For EBITDA | 9.3 | 9.29 | 7.54 | 0.82 | 1.77 | 2.85 | Upgrade
|
| EBIT | -41.09 | -51.26 | -59.14 | -31.93 | -28.09 | -15.79 | Upgrade
|
| EBIT Margin | -140.83% | -183.46% | - | -132.79% | - | - | Upgrade
|
| Advertising Expenses | - | 0.11 | 0.3 | 0.7 | 0.67 | 0.21 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.